Filing Details
- Accession Number:
- 0001388658-23-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 18:09:48
- Reporting Period:
- 2023-02-27
- Accepted Time:
- 2023-03-01 18:09:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769845 | J. Mark Day | C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-02-27 | 8,354 | $0.00 | 55,376 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2023-02-27 | 3,468 | $0.00 | 58,844 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-02-28 | 1,898 | $117.83 | 56,946 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-28 | 15 | $119.28 | 56,931 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- Includes 303 shares acquired under the Issuer's employee stock purchase plan on May 31, 2022.
- Includes 14 shares acquired under the Issuer's employee stock purchase plan on November 30, 2022.
- Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance RSUs granted to the Reporting Person on February 25, 2020.
- These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.